184 related articles for article (PubMed ID: 19641159)
21. Increased plasma monocyte chemoattractant protein-1 levels in patients with isolated low high-density lipoprotein cholesterol.
Karabacak M; Kahraman F; Sert M; Celik E; Adali MK; Varol E
Scand J Clin Lab Invest; 2015 Jul; 75(4):327-32. PubMed ID: 25797068
[TBL] [Abstract][Full Text] [Related]
22. Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study.
Wei M; Gaskill SP; Haffner SM; Stern MP
Diabetes Care; 1998 Jul; 21(7):1167-72. PubMed ID: 9653614
[TBL] [Abstract][Full Text] [Related]
23. Circulating leptin levels are not associated with cardiovascular morbidity and mortality in women with diabetes: a prospective cohort study.
Brennan AM; Li TY; Kelesidis I; Gavrila A; Hu FB; Mantzoros CS
Diabetologia; 2007 Jun; 50(6):1178-85. PubMed ID: 17372717
[TBL] [Abstract][Full Text] [Related]
24. Increased levels of CRP and MCP-1 are associated with previously unknown abnormal glucose regulation in patients with acute STEMI: a cohort study.
Knudsen EC; Seljeflot I; Michael A; Eritsland J; Mangschau A; Müller C; Arnesen H; Andersen GØ
Cardiovasc Diabetol; 2010 Sep; 9():47. PubMed ID: 20809989
[TBL] [Abstract][Full Text] [Related]
25. C-reactive protein and 5-year survival in type 2 diabetes: the Casale Monferrato Study.
Bruno G; Fornengo P; Novelli G; Panero F; Perotto M; Segre O; Zucco C; Deambrogio P; Bargero G; Perin PC
Diabetes; 2009 Apr; 58(4):926-33. PubMed ID: 19074985
[TBL] [Abstract][Full Text] [Related]
26. Soluble ST2 is a biomarker for cardiovascular mortality related to abnormal glucose metabolism in high-risk subjects.
Cardellini M; Rizza S; Casagrande V; Cardolini I; Ballanti M; Davato F; Porzio O; Canale MP; Legramante JM; Mavilio M; Menghini R; Martelli E; Farcomeni A; Federici M
Acta Diabetol; 2019 Mar; 56(3):273-280. PubMed ID: 30259114
[TBL] [Abstract][Full Text] [Related]
27. Adiponectin and E-selectin concentrations in relation to inflammation in obese type 2 diabetic patients with coronary heart disease(s).
El-Mesallamy HO; Hamdy NM; Salman TM; Mahmoud S
Minerva Endocrinol; 2011 Sep; 36(3):163-70. PubMed ID: 22019747
[TBL] [Abstract][Full Text] [Related]
28. Initiation of insulin therapy reduces serum concentrations of high-sensitivity C-reactive protein in patients with type 2 diabetes.
Takebayashi K; Aso Y; Inukai T
Metabolism; 2004 Jun; 53(6):693-9. PubMed ID: 15164314
[TBL] [Abstract][Full Text] [Related]
29. Insulin resistance as a predictor of cardiovascular morbidity and end-stage renal disease.
Fragoso A; Mendes F; Silva AP; Neves PL
J Diabetes Complications; 2015; 29(8):1098-104. PubMed ID: 26066409
[TBL] [Abstract][Full Text] [Related]
30. Non-Classical Monocytes and Monocyte Chemoattractant Protein-1 (MCP-1) Correlate with Coronary Artery Calcium Progression in Chronically HIV-1 Infected Adults on Stable Antiretroviral Therapy.
Zungsontiporn N; Tello RR; Zhang G; Mitchell BI; Budoff M; Kallianpur KJ; Nakamoto BK; Keating SM; Norris PJ; Ndhlovu LC; Souza SA; Shikuma CM; Chow DC
PLoS One; 2016; 11(2):e0149143. PubMed ID: 26867220
[TBL] [Abstract][Full Text] [Related]
31. Systemic monocyte chemoattractant protein-1 concentrations are independent of type 2 diabetes or parameters of obesity: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4).
Herder C; Müller-Scholze S; Rating P; Koenig W; Thorand B; Haastert B; Holle R; Illig T; Rathmann W; Seissler J; Wichmann HE; Kolb H
Eur J Endocrinol; 2006 Feb; 154(2):311-7. PubMed ID: 16452546
[TBL] [Abstract][Full Text] [Related]
32. The MCP-1 Gene A-2518G Polymorphism Confers an Increased Risk of Vascular Complications in Type 2 Diabetes Mellitus Patients.
Xu J; Liao YF; Zhou WP; Ming HL; Wang QH
Genet Test Mol Biomarkers; 2015 Aug; 19(8):411-7. PubMed ID: 26083329
[TBL] [Abstract][Full Text] [Related]
33. Effects of vitamin D supplementation on circulatory YKL-40 and MCP-1 biomarkers associated with vascular diabetic complications: A randomized, placebo-controlled, double-blind clinical trial.
Omidian M; Mahmoudi M; Javanbakht MH; Eshraghian MR; Abshirini M; Daneshzad E; Hasani H; Alvandi E; Djalali M
Diabetes Metab Syndr; 2019; 13(5):2873-2877. PubMed ID: 31425951
[TBL] [Abstract][Full Text] [Related]
34. Monocyte chemoattractant protein-1 (MCP-1) and fibroblast growth factor-21 (FGF-21) as biomarkers of subclinical atherosclerosis in women.
Basurto L; Gregory MA; Hernández SB; Sánchez-Huerta L; Martínez AD; Manuel-Apolinar L; Avelar FJ; Alonso LAM; Sánchez-Arenas R
Exp Gerontol; 2019 Sep; 124():110624. PubMed ID: 31152776
[TBL] [Abstract][Full Text] [Related]
35. C-reactive protein and incident cardiovascular events among men with diabetes.
Schulze MB; Rimm EB; Li T; Rifai N; Stampfer MJ; Hu FB
Diabetes Care; 2004 Apr; 27(4):889-94. PubMed ID: 15047644
[TBL] [Abstract][Full Text] [Related]
36. Plasma monocyte chemoattractant protein-1 as risk marker in type 2 diabetes mellitus and coronary artery disease in North Indians.
Harsimran K; Singh AA; Guruvinder S; Sharda S; Vasudha S
Diab Vasc Dis Res; 2009 Oct; 6(4):288-90. PubMed ID: 20368224
[TBL] [Abstract][Full Text] [Related]
37. [Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation].
Vanuzzo D; Pilotto L; Mirolo R; Pirelli S
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):6S-17S. PubMed ID: 18773746
[TBL] [Abstract][Full Text] [Related]
38. Insulin resistance, leptin and monocyte chemotactic protein-1 levels in diabetic and non-diabetic Afro-Caribbean subjects.
Ezenwaka CE; Nwagbara E; Seales D; Okali F; Sell H; Eckel J
Arch Physiol Biochem; 2009 Feb; 115(1):22-7. PubMed ID: 19267279
[TBL] [Abstract][Full Text] [Related]
39. Metabolic and cardiovascular risk factors in subjects with impaired fasting glucose: the 100 versus 110 mg/dL threshold.
Andreozzi F; Succurro E; Mancuso MR; Perticone M; Sciacqua A; Perticone F; Sesti G
Diabetes Metab Res Rev; 2007 Oct; 23(7):547-50. PubMed ID: 17311284
[TBL] [Abstract][Full Text] [Related]
40. Hypertriglyceridemia in different degrees of glucose intolerance in a Finnish population-based study.
Salomaa VV; Tuomilehto J; Jauhiainen M; Korhonen HJ; Stengård J; Uusitupa M; Pitkanen M; Penttila I
Diabetes Care; 1992 May; 15(5):657-65. PubMed ID: 1516486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
